Lixte Biotechnology【LIXT】銘柄情報

Lixte Biotechnology Holdings Inc (LIXT) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

7.58

( -1.17% )

買値

7.15

売値

7.59

出来高

615,069

7.00 日の範囲 7.99

1.28 52 週間の範囲 8.3773

時価総額

93.863M

前日終値

7.67

始値

7.95

時刻

197

7.58

(formt)

最終取引時間

財務取引量

US$ 4,493,887

VWAP

7.3063

平均取引量 (3 か月)

US$ 179,909

発行済株式数

12,382,944

配当利回り

PER

-6.83

1 株当たり利益 (EPS)

-1.05

歳入

純利益

-7.22M

Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical and proton cancer therapy company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with A... Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical and proton cancer therapy company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company’s LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Boca Raton, Florida. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

lixte.com

本社

Boca Raton, United States

設立

2026

Lixte Biotechnology Holdings Inc is listed in the Healthcare sector of the ナスダック市場 with ticker LIXT. The last closing price for Lixte Biotechnology was US$7.67. Over the last year, Lixte Biotechnology shares have traded in a share price range of US$ 1.28 to US$ 8.3773.

Lixte Biotechnology currently has 12,382,944 shares in issue. The market capitalisation of Lixte Biotechnology is US$93.86 million. Lixte Biotechnology has a price to earnings ratio (PE ratio) of -6.83.

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 3 - Initial statement of beneficial ownership of securities

LIXTE COMPLETES MERGER WITH NOMAD TRANSPORTABLE POWER SYSTEMS

-Transaction Transforms LIXTE to New Growth Sector Addressing Multi-Billion-Dollar Market of Mobile...

LIXTE Joins Russell Microcap Index

BOCA RATON, Fla., June 26, 2026 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the...

Form 8-K - Current report

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.64	9.22190201729	6.94	8.3773	6.55	681785	7.634569	CS
4	0.87	12.9657228018	6.71	8.3773	5.875	517729	7.21539619	CS
12	4.51	146.905537459	3.07	8.3773	2.71	239281	6.76486499	CS
26	3.68	94.358974359	3.9	8.3773	2.36	146051	5.95121581	CS
52	6.27	478.625954198	1.31	8.3773	1.28	574830	3.20165409	CS
156	1.87	32.7495621716	5.71	9.5	0.64	335249	2.98298433	CS
260	4.41	139.116719243	3.17	9.5	0.432	594566	2.25019006	CS